Anti-c-myc Antibody Conjugated to DyLight 488

Product Description

Anti-c-myc Antibody Conjugated to DyLight 488
Catalog number: B2011228
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 µg
Molecular Weight or Concentration: 1 mg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20 °C
Keywords: c-Myc antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Li H, Liu J, Cao W, Xiao X, Liang L, Liu-Smith F, Wang W, Liu H, Zhou P, Ouyang R, Yuan Z, Liu J, Ye M, Zhang B. C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer Theranostics. 2019 Jul 9;9(18):5134-5148.
2: Gazitt Y, He YJ, Erdos GW, Chang L, Ashktorab H, Cohen RJ. Development of a two color immunofluorescence stain and immunolocalization method for N-myc and c-myc oncoproteins with a newly generated mouse IgM anti N-myc antibody J Immunol Methods. 1992 Apr 8;148(1-2):159-69.
3: Fan-Minogue H, Bodapati S, Solow-Cordero D, Fan A, Paulmurugan R, Massoud TF, Felsher DW, Gambhir SS. A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide Mol Cancer Ther. 2013 Sep;12(9):1896-905.
4: Varughese M, Chi A, Teixeira AV, Nicholls PJ, Keith JM, Leppla SH. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies Mol Med. 1998 Feb;4(2):87-95.
5: Huang Y, Snyder R, Kligshteyn M, Wickstrom E. Prevention of tumor formation in a mouse model of Burkitt’s lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate Mol Med. 1995 Sep;1(6):647-58.
6: Wickstrom E, Bacon TA, Wickstrom EL. Down-regulation of c-MYC antigen expression in lymphocytes of Emu-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates Cancer Res. 1992 Dec 15;52(24):6741-5.
7: Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Specks U. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases J Immunol Methods. 2005 Dec 20;307(1-2):62-72.
8: Tulchin N, Ornstein L, Harpaz N, Guillem J, Borner C, O’Toole K. c-myc protein distribution. Neoplastic tissues of the human colon Am J Pathol. 1992 Mar;140(3):719-29.
9: Tulchin N, Ornstein L, Bleiweiss I, Dikman S, Cardiff R. Immunohistologic c-myc protein in benign breast disease and cancer Int J Oncol. 1996 Sep;9(3):419-25.
10: Stepanov AV, Belogurov AA Jr, Ponomarenko NA, Stremovskiy OA, Kozlov LV, Bichucher AM, Dmitriev SE, Smirnov IV, Shamborant OG, Balabashin DS, Sashchenko LP, Tonevitsky AG, Friboulet A, Gabibov AG, Deyev SM. Design of targeted B cell killing agents PLoS One. 2011;6(6):e20991.

Products Related to Anti-c-myc Antibody Conjugated to DyLight 488 can be found at Conjugates